For the first time in history, a personalized mRNA cancer vaccine has passed a Phase 3 clinical trial. Robert Lufkin MD breaks down the Moderna/Merck melanoma result, how a vaccine custom-built from your own tumor actually works, the 49% drop in recurrence risk behind the headlines — and the honest answer to whether mRNA vaccines will cure cancer.

In this episode of Health Longevity Secrets, Robert Lufkin MD explains the science of personalized mRNA cancer vaccines: neoantigens, the AI-designed "most wanted poster" for your immune system, the five-year KEYNOTE-942 data, the stunning pancreatic cancer signal from Memorial Sloan Kettering, the BioNTech colorectal trial shutdown that reminds us why we run trials — and what still sits upstream of it all: your metabolic health.

Chapters:

00:00 — Introduction: A Cancer Vaccine Makes History
00:43 — What Just Happened: Moderna/Merck Phase 3 Melanoma Trial
01:44 — A Vaccine Made From Your Own Tumor: How It Works
02:31 — Neoantigens: A "Most Wanted Poster" for Your T-Cells
03:17 — The Numbers Behind the Hype: 49% Lower Recurrence at 5 Years
03:53 — Pancreatic Cancer Vaccine: The Sloan Kettering Survival Signal
04:44 — So Will mRNA Vaccines Cure Cancer? The Honest Answer
05:40 — The Platform Play: Lung, Kidney & Prostate Cancer Trials
06:09 — The Honest Caveats: Press Releases vs Peer Review
06:45 — The Colorectal Trial Shutdown: A Reality Check
07:57 — The Takeaway: Metabolic Health Still Sits Upstream

Key takeaways:

Intismeran autogene + Keytruda is the first mRNA cancer vaccine to succeed in a Phase 3 trial — FDA approval possibly by early 2027.
These are NOT prevention shots — each dose is custom-built from one patient's tumor mutations to hunt residual cancer cells after surgery.
Five-year Phase 2b data (KEYNOTE-942): 49% lower risk of recurrence or death, and 62% lower risk of distant metastasis or death at three years.
Pancreatic trial (n=16): ~90% of immune responders alive 4–6 years after surgery vs ~25% of non-responders — hypothesis-generating, not proof.
The reality check: BioNTech/Genentech halted a colorectal Phase 2 after MORE deaths in the vaccine-alone arm — same technology, different cancer, opposite result.
The Phase 3 result is a top-line press release, not yet peer-reviewed; the vaccine is not FDA-approved and is only available in clinical trials today.
Muscle, blood sugar control, sleep, not smoking, and sun protection remain the most proven cancer-risk tools you own right now.

Studies & sources:

Dr. Lufkin's book Lies I Taught in Medical School — more at robertlufkinmd.com and the Health Longevity Brief on Substack.

⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!

New episodes every other Tuesday. Subscribe so you don't miss one.

Continue this conversation on Substack: https://robertlufkinmd.substack.com

Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/

Web: https://www.robertlufkinmd.com
YouTube: https://www.youtube.com/robertlufkinmd
X: https://x.com/robertlufkinmd
Instagram: https://www.instagram.com/robertlufkinmd/
TikTok: https://www.tiktok.com/@robertlufkin
LinkedIn: https://www.linkedin.com/in/robertlufkinmd/

EXPLAINER: Will mRNA Vaccines Cure Cancer?

Health Longevity Secrets

EXPLAINER: Will mRNA Vaccines Cure Cancer?